Form D · Biotechnology
Elcelyx Therapeutics, Inc.
San Diego, CA · CIK 0001486988
Offering snapshot reported Nov 7, 2018 · SEC filing
- Reported sold
- $476K Offering amount: $1M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 24, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2018 | Initial | $476,484 | No comparison | 2 | SEC filing |
| Oct 7, 2015 | Initial | $20,092,879 | No comparison | 13 | SEC filing |
| Feb 19, 2015 | Initial | $5,823,326 | No comparison | 8 | SEC filing |
| Feb 21, 2014 | Amendment | $24,720,101 | $12,720,099vs Feb 26, 2013 | 7 | SEC filing |
| Feb 26, 2013 | Initial | $12,000,002 | No comparison | 7 | SEC filing |
| Dec 20, 2012 | Amendment | $21,125,008 | $2,999,994vs Aug 13, 2012 | 7 | SEC filing |
| Aug 13, 2012 | Amendment | $18,125,014 | $12,075,013vs Jan 26, 2011 | 7 | SEC filing |
| May 10, 2011 | Amendment | $14,125,007 | $8,075,006vs Jan 26, 2011 | 7 | SEC filing |
| Jan 26, 2011 | Initial | $6,050,001 | No comparison | 4 | SEC filing |
| Mar 17, 2010 | Initial | $1,200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-325277
Source: Form D, filed Nov 7, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alain Baron | Director, Executive |
| Richard Barry | Director |
| Martin R. Brown | Executive |
| Brook Byers | Director |
| Ralph E. Christoffersen | Director |
| Ralph E. Christofferson | Director |
| Mark Fineman | Executive |
| Jim Glasheen | Director |
| Ginger Graham | Director |
| Bosun Hau | Director |
| Christopher R. G. Jones | Executive |
| Theodore A. Laufik | Director, Executive |
| Sandy Mahatme | Director |
| Christoffersen Ralph | Director |
| Jay Sherwood | Executive |
| Liang Tsui | Director |
| Mark Wiggins | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3033 Science Park Road, Suite 230
San Diego, CA, 92121
San Diego, CA, 92121